rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
20
|
pubmed:dateCreated |
1995-12-13
|
pubmed:abstractText |
To determine whether the effects of topically administered timolol in an individual would be dependent on the presence or absence in that individual of the P-450 enzyme CYP2D6 and whether the effects of topically administered timolol would be increased and its metabolism decreased by the oral administration of quinidine, a known inhibitor of CYP2D6.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0098-7484
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1611-3
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7474246-Administration, Oral,
pubmed-meshheading:7474246-Administration, Topical,
pubmed-meshheading:7474246-Adrenergic beta-Antagonists,
pubmed-meshheading:7474246-Adult,
pubmed-meshheading:7474246-Cross-Over Studies,
pubmed-meshheading:7474246-Cytochrome P-450 CYP2D6,
pubmed-meshheading:7474246-Cytochrome P-450 Enzyme System,
pubmed-meshheading:7474246-Debrisoquin,
pubmed-meshheading:7474246-Drug Interactions,
pubmed-meshheading:7474246-Enzyme Inhibitors,
pubmed-meshheading:7474246-Exercise Test,
pubmed-meshheading:7474246-Heart Rate,
pubmed-meshheading:7474246-Humans,
pubmed-meshheading:7474246-Male,
pubmed-meshheading:7474246-Mixed Function Oxygenases,
pubmed-meshheading:7474246-Ophthalmic Solutions,
pubmed-meshheading:7474246-Phenotype,
pubmed-meshheading:7474246-Quinidine,
pubmed-meshheading:7474246-Single-Blind Method,
pubmed-meshheading:7474246-Timolol
|
pubmed:articleTitle |
Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.
|
pubmed:affiliation |
Department of Pharmacology, Meharry Medical College, Nashville, Tenn, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|